Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Nuvation Bio Inc. Director's Dealing 2024

Jan 10, 2024

32154_dirs_2024-01-10_0c77087c-6b36-413a-82ca-75b8f21d628d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2024-01-08

Reporting Person: Mashal Robert (N/A)

More from Nuvation Bio Inc.

Declaration of Voting Results & Voting Rights Announcements 2026
May 27
Annual Report 2026
Apr 10
Proxy Solicitation & Information Statement 2026
Apr 10
Director's Dealing 2026
Mar 4
Director's Dealing 2026
Mar 4
Director's Dealing 2026
Mar 4
Director's Dealing 2026
Mar 4
Director's Dealing 2026
Mar 4
Director's Dealing 2026
Mar 4
Director's Dealing 2026
Mar 4
View all filings →